rs121913476, FGFR2

N. diseases: 7
Disease: endometrial adenoacanthoma ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
endometrial adenoacanthoma
CUI: C0279763
Disease: endometrial adenoacanthoma
0.700 GeneticVariation CLINVAR The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors. 23908597 2013
endometrial adenoacanthoma
CUI: C0279763
Disease: endometrial adenoacanthoma
0.700 GeneticVariation CLINVAR The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors. 23908597 2013
endometrial adenoacanthoma
CUI: C0279763
Disease: endometrial adenoacanthoma
0.700 GeneticVariation CLINVAR Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models. 22238366 2012
endometrial adenoacanthoma
CUI: C0279763
Disease: endometrial adenoacanthoma
0.700 GeneticVariation CLINVAR FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor. 23002168 2012
endometrial adenoacanthoma
CUI: C0279763
Disease: endometrial adenoacanthoma
0.700 GeneticVariation CLINVAR FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor. 23002168 2012
endometrial adenoacanthoma
CUI: C0279763
Disease: endometrial adenoacanthoma
0.700 GeneticVariation CLINVAR Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models. 22238366 2012
endometrial adenoacanthoma
CUI: C0279763
Disease: endometrial adenoacanthoma
0.700 GeneticVariation CLINVAR Drug-sensitive FGFR2 mutations in endometrial carcinoma. 18552176 2008
endometrial adenoacanthoma
CUI: C0279763
Disease: endometrial adenoacanthoma
0.700 GeneticVariation CLINVAR Drug-sensitive FGFR2 mutations in endometrial carcinoma. 18552176 2008